Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-108851·Catalys Pacific Fund, LP
Schedule 13G ownership disclosure
Mineralys Therapeutics Inc
Common Stock, par value $0.0001 per share · CUSIP: 603170101
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Catalys Pacific Fund, LP
Shares: 8,978,954 · Class: 13.5%
- Catalys Pacific Fund GP, LP
Shares: 8,978,954 · Class: 13.5%
- Catalys Pacific, LLC
Shares: 8,978,954 · Class: 13.5%
- Brian Taylor Slingsby
Shares: 8,978,954 · Class: 13.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-108851
- Form type
- SCHEDULE 13G/A
- Filer
- Catalys Pacific Fund, LP
- CIK
- CIK 1746274
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership